Drug Information

Drug General Information
Drug ID
D0GY0O
Former ID
DIB002345
Drug Name
BAY-X-7195
Drug Type
Small molecular drug
Indication Asthma [ICD10:J45] Phase 2 [545585]
Company
Bayer AG
Formula
C30H32O6S
Canonical SMILES
C(=O)(c1ccc(S[C@H](/C=C\Cc2ccc(cc2)OCCCCOc2ccccc2)CCC(=<br />O)O)cc1)O
CAS Number
CAS 143538-27-6
PubChem Compound ID
6442328
Target and Pathway
Target(s) Cysteinyl leukotriene receptor 1 Target Info Modulator
Leukotriene CysLT2 receptor Target Info Modulator
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interactionhsa04020:Calcium signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway TGF_beta_Receptor Signaling Pathway
IL4 Signaling Pathway
IL3 Signaling PathwayNetPath_16:IL4 Signaling Pathway
IL3 Signaling Pathway
Pathway Interaction Database Endothelinsendothelinpathway:Endothelins
Reactome Leukotriene receptors
G alpha (q) signalling eventsR-HSA-391906:Leukotriene receptors
G alpha (q) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
GPCR downstream signaling
References
Ref 545585Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003794)